InsidersTradesSigma
申报总数
公司
▲ 买入（0 笔）
▼ 卖出（3 笔）
内部人交易记录
董事已披露买入
0
已披露卖出
3
尚无足够的、已确定 T+90 期限的买入信号来衡量交易记录。
信号历史
Explore the full record of transactions filed by Kauffman Michael, 董事. Insider active across 4 companies, notably Kezar Life Sciences, Inc.. Aggregated, 9 reports have been published. Breakdown: 0 buy · 3 sells. Total volume traded: €229k. History available since 3 January 2022. The latest transaction was disclosed on 21 November 2025 (Cession). Regulator: SEC (Form 4). The full history is accessible without signup.
Companies and markets linked to Kauffman Michael
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
申报9 总计
8,550 股@ US$10.00100.0% 占其流量Common StockSEC:0001104659-25-116060:0
8,333 股0Common StockSEC:0001104659-25-053096:0
8,333 股0Common StockSEC:0001104659-24-073606:0
5,900 股0Common StockSEC:0000950170-24-070605:0
5,900 股0Common StockSEC:0001209191-23-033959:0
21,000 股0Common StockSEC:0001209191-22-014624:0
9,079 股@ US$12.123462.4% 占其流量Common StockSEC:0001209191-22-011636:0
6,764 股@ US$9.86237.6% 占其流量Common StockSEC:0001209191-22-008124:0
5,000 股@ US$5.91100.0% 占其流量Common StockSEC:0001209191-22-001964:0
9 条申报中的 9 条
About Kauffman Michael
Kauffman Michael is Administrateur and a Director at Verastem, Inc., Karyopharm Therapeutics Inc., Adicet Bio, Inc. and Kezar Life Sciences, Inc. The 9 filings in the recent sample cover the period from 2022-01-05 to 2025-11-25, with 0 in buys and 229119 in sells, and the modal transaction nature is Attribution.
